Read the First Edition of The Lens, a new magazine by LSI arrow-icon
Learn More About NeuroPhage Pharmaceuticals
NeuroPhage Pharmaceuticals
Reports Graph
Unique multi-target approach to reducing pathologic deposits of misfolded proteins, for the treatment and prevention of chronic neurodegenerative diseases
Technology/product details
Revenue projections
Capital raised to date
Growth strategy
Competing Startups
More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Spineology plus 6164 other startups.

Trusted By The Companies Pioneering What’s Next